Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics

Trial enrichment using gut microbiota derived biomarkers by high-risk individuals can improve the feasibility of randomized controlled trials for prevention of Clostridioides difficile infection (CDI). Here, we report in a prospective observational cohort study the incidence of CDI and assess potent...

Descripción completa

Detalles Bibliográficos
Autores principales: van Werkhoven, Cornelis H., Ducher, Annie, Berkell, Matilda, Mysara, Mohamed, Lammens, Christine, Torre-Cisneros, Julian, Rodríguez-Baño, Jesús, Herghea, Delia, Cornely, Oliver A., Biehl, Lena M., Bernard, Louis, Dominguez-Luzon, M. Angeles, Maraki, Sofia, Barraud, Olivier, Nica, Maria, Jazmati, Nathalie, Sablier-Gallis, Frederique, de Gunzburg, Jean, Mentré, France, Malhotra-Kumar, Surbhi, Bonten, Marc J. M., Vehreschild, Maria J. G. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046770/
https://www.ncbi.nlm.nih.gov/pubmed/33854064
http://dx.doi.org/10.1038/s41467-021-22269-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046770/
https://www.ncbi.nlm.nih.gov/pubmed/33854064
http://dx.doi.org/10.1038/s41467-021-22269-y

Ejemplares similares